We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+19.18%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.1B
AUM Growth
+$3.8B
Cap. Flow
+$2.09B
Cap. Flow %
14.81%
Top 10 Hldgs %
19.63%
Holding
2,124
New
675
Increased
443
Reduced
410
Closed
576

Top Buys

Rank Stock Value
1
FIS icon
Fidelity National Information Services
FIS
+$188M
2
AMZN icon
Amazon
AMZN
+$137M
3
ADBE icon
Adobe
ADBE
+$110M
4
EA
Electronic Arts
EA
+$110M
5
PFE icon
Pfizer
PFE
+$109M

Top Sells

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$131M
2
MSFT icon
Microsoft
MSFT
+$129M
3
V icon
Visa
V
+$119M
4
BKNG icon
Booking.com
BKNG
+$86M
5
HUM icon
Humana
HUM
+$82.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.67%
2 Technology 15.37%
3 Consumer Discretionary 10.44%
4 Industrials 8.59%
5 Financials 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBLK icon
1276
Star Bulk Carriers
SBLK
$3.22B
$47K ﹤0.01%
+7,108
New +$57.1K
LEGH icon
1277
Legacy Housing
LEGH
$694M
$46K ﹤0.01%
+3,837
New +$51.1K
MDU icon
1278
MDU Resources
MDU
$4.32B
$46K ﹤0.01%
4,734
-2,990
-39% -$29K
CIB icon
1279
Grupo Cibest SA
CIB
$21.1B
$45K ﹤0.01%
890
-12,665
-93% -$590K
INSP icon
1280
Inspire Medical Systems
INSP
$1.74B
$45K ﹤0.01%
+800
New +$43.2K
OTLKW
1281
DELISTED
Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022
OTLKW
$45K ﹤0.01%
125,400
– –
UFS
1282
DELISTED
DOMTAR CORPORATION (New)
UFS
$45K ﹤0.01%
900
-44,299
-98% -$2.11M
AVA icon
1283
Avista
AVA
$3.24B
$44K ﹤0.01%
1,094
-55,095
-98% -$2.26M
EPC icon
1284
Edgewell Personal Care
EPC
$1.31B
$44K ﹤0.01%
1,000
-8,465
-89% -$353K
GPC icon
1285
Genuine Parts
GPC
$18.7B
$44K ﹤0.01%
+389
New +$40.2K
NGVT icon
1286
Ingevity
NGVT
$2.68B
$44K ﹤0.01%
411
-50,818
-99% -$5.1M
OUT icon
1287
Outfront Media
OUT
$5.5B
$44K ﹤0.01%
+1,930
New +$40.5K
PRAA icon
1288
PRA Group
PRAA
$755M
$44K ﹤0.01%
1,655
+410
+33% +$11.9K
VSM
1289
DELISTED
Versum Materials, Inc.
VSM
$44K ﹤0.01%
866
-43,673
-98% -$1.74M
CMTA
1290
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
$44K ﹤0.01%
+1,685
New +$31.5K
CRNX icon
1291
Crinetics Pharmaceuticals
CRNX
$8.92B
$43K ﹤0.01%
+1,911
New +$47K
ADC icon
1292
Agree Realty
ADC
$9.41B
$42K ﹤0.01%
600
-108,909
-99% -$7.05M
DRH icon
1293
Diamondrock Hospitality Co
DRH
$2.56B
$42K ﹤0.01%
3,862
-86,418
-96% -$894K
PRA
1294
DELISTED
ProAssurance
PRA
$42K ﹤0.01%
+1,200
New +$48.6K
JBGS
1295
JBG SMITH
JBGS
$708M
$41K ﹤0.01%
+1,000
New +$39.2K
SCOR icon
1296
Comscore
SCOR
$109M
$41K ﹤0.01%
+101
New +$41.1K
OMP
1297
DELISTED
Oasis Midstream Partners LP Common Units Representing Limited Partner Interests
OMP
$41K ﹤0.01%
+1,998
New +$38.7K
JCP
1298
DELISTED
J.C. Penney Company, Inc.
JCP
$41K ﹤0.01%
+27,404
New +$38.6K
QADA
1299
DELISTED
QAD Inc.
QADA
$41K ﹤0.01%
+961
New +$41.2K
ARTNA icon
1300
Artesian Resources
ARTNA
$358M
$40K ﹤0.01%
+1,083
New +$40.1K
50 51
52
53 54

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q1 2019 Portfolio in Review

As of Q1 2019, Marshall Wace North America held 2,124 positions worth $14.1B, up 37% from $10.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace North America deployed $2.09B of net new capital in Q1 2019, opening 675 new positions and adding to 443 existing holdings. Its largest new stake was bluebird bio: 36,744 shares worth $74.9M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Comcast, an estimated $131M trimmed.

  • Marshall Wace North America's largest Q1 2019 buy was bluebird bio: 36,744 shares worth $74.9M.
  • Marshall Wace North America added most to Fidelity National Information Services in Q1 2019, an estimated $188M increase.
  • Marshall Wace North America's biggest Q1 2019 reduction was Comcast, cutting an estimated $131M.
  • Marshall Wace North America fully exited Cboe Global Markets in Q1 2019, selling an estimated $67.7M.
  • Marshall Wace North America's ten largest holdings make up 20% of its $14.1B portfolio in Q1 2019.
  • Marshall Wace North America opened 675 new positions and closed 576 in Q1 2019.
  • Marshall Wace North America's portfolio value rose 37% quarter-over-quarter to $14.1B.

Based on Marshall Wace North America's 13F filing for Q1 2019, filed 14 May 2019.